Fractyl Health Inc. Commo... (GUTS)
Fractyl Health Common Stock Statistics
Share Statistics
Fractyl Health Common Stock has 48.92M shares outstanding. The number of shares has increased by 2.14% in one year.
Shares Outstanding | 48.92M |
Shares Change (YoY) | 2.14% |
Shares Change (QoQ) | 1.71% |
Owned by Institutions (%) | n/a |
Shares Floating | 20.85M |
Failed to Deliver (FTD) Shares | 4.74K |
FTD / Avg. Volume | 1.61% |
Short Selling Information
The latest short interest is 2.73M, so 5.67% of the outstanding shares have been sold short.
Short Interest | 2.73M |
Short % of Shares Out | 5.67% |
Short % of Float | 13.21% |
Short Ratio (days to cover) | 7.03 |
Valuation Ratios
The PE ratio is -1.31 and the forward PE ratio is -0.78. Fractyl Health Common Stock's PEG ratio is 0.07.
PE Ratio | -1.31 |
Forward PE | -0.78 |
PS Ratio | 964.47 |
Forward PS | 713.4 |
PB Ratio | 3.16 |
P/FCF Ratio | -1.33 |
PEG Ratio | 0.07 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Fractyl Health Common Stock.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.63, with a Debt / Equity ratio of 2.2.
Current Ratio | 3.63 |
Quick Ratio | 3.63 |
Debt / Equity | 2.2 |
Debt / EBITDA | -0.67 |
Debt / FCF | -0.93 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $869.16 |
Profits Per Employee | $-642K |
Employee Count | 107 |
Asset Turnover | 0 |
Inventory Turnover | 0.68 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -84.76% in the last 52 weeks. The beta is 0.3, so Fractyl Health Common Stock's price volatility has been higher than the market average.
Beta | 0.3 |
52-Week Price Change | -84.76% |
50-Day Moving Average | 1.48 |
200-Day Moving Average | 2.5 |
Relative Strength Index (RSI) | 36.31 |
Average Volume (20 Days) | 294.62K |
Income Statement
In the last 12 months, Fractyl Health Common Stock had revenue of 93K and earned -68.69M in profits. Earnings per share was -1.62.
Revenue | 93K |
Gross Profit | 43K |
Operating Income | -93.53M |
Net Income | -68.69M |
EBITDA | -92.85M |
EBIT | -93.53M |
Earnings Per Share (EPS) | -1.62 |
Balance Sheet
The company has 67.46M in cash and 62.5M in debt, giving a net cash position of 4.96M.
Cash & Cash Equivalents | 67.46M |
Total Debt | 62.5M |
Net Cash | 4.96M |
Retained Earnings | -415.31M |
Total Assets | 108.08M |
Working Capital | 51.99M |
Cash Flow
In the last 12 months, operating cash flow was -65.52M and capital expenditures -1.76M, giving a free cash flow of -67.29M.
Operating Cash Flow | -65.52M |
Capital Expenditures | -1.76M |
Free Cash Flow | -67.29M |
FCF Per Share | -1.55 |
Margins
Gross margin is 46.24%, with operating and profit margins of -100570.97% and -73864.52%.
Gross Margin | 46.24% |
Operating Margin | -100570.97% |
Pretax Margin | -73864.52% |
Profit Margin | -73864.52% |
EBITDA Margin | -99843.01% |
EBIT Margin | -100570.97% |
FCF Margin | -72350.54% |
Dividends & Yields
GUTS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for GUTS is $10, which is 777.2% higher than the current price. The consensus rating is "Buy".
Price Target | $10 |
Price Target Difference | 777.2% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Scores
Altman Z-Score | -7.25 |
Piotroski F-Score | 5 |